ArticleTargeted oncology2020

Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study".

Yusuf Ziya ŞenerPubMed ↗Publisher ↗

No numbers read from the abstract.